Skip to main content
SpringerLink
Log in

Autosomal dominante polyzystische Nierenerkrankung (ADPKD)

SpringerReference Innere Medizin

Part of the book series: SpringerReference Medizin ((SRM))

  • 288 Accesses

Zusammenfassung

Die autosomal dominante polyzystische Nierenerkrankung ist eine monogenetische Nierenerkrankung, die in der Regel in der zweiten bis dritten Lebensdekade beginnt, typischerweise aber erst nach dem 40–50. Lebensjahr durch Schmerzen, welche durch das Zystenwachstum und -rupturen verursacht werden, Hypertonie und zunehmender Nierenfunktionsstörung in Erscheinung tritt. Die Kombination von stark vergrößerten Nieren mit multiplen beidseitigen Zysten unterschiedlicher Größe, Zysten in anderen Organen insbesondere der Leber in Verbindung mit einer eingeschränkten Nierenfunktion und einer positiven Familienanamnese sind praktisch diagnostisch für diese Erkrankung.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  • Barr MM et al (2001) The Caenorhabditis elegans autosomal dominant polycystic kidney disease gene homologs lov-1 and pkd-2 act in the same pathway. Curr Biol 11:1341–1346

    Article  CAS  PubMed  Google Scholar 

  • Boehlke C et al (2010) Primary cilia regulate mTORC1 activity and cell size through Lkb1. Nat Cell Biol 12:1115–1122

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Brisman JL, Song JK, Newell DW (2006) Cerebral aneurysms. N Engl J Med 355:928–939

    Article  CAS  PubMed  Google Scholar 

  • Chapman AB et al (2012) Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 7:479–486

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Gevers TJ, Chrispijn M, Wetzels JF, Drenth JP (2012) Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease. BMC Nephrol 13:17

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Grantham JJ, Ye M, Davidow C, Holub B, Sharma M (1995) Evidence for a potent lipid secretagogue in the cyst fluids of patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 6:1242–1249

    CAS  PubMed  Google Scholar 

  • Grantham JJ et al (2006) Volume progression in polycystic kidney disease. N Engl J Med 354:2122–2130

    Article  CAS  PubMed  Google Scholar 

  • Haseebuddin M et al (2012) Long-term impact of laparoscopic cyst decortication on renal function, hypertension and pain control in patients with autosomal dominant polycystic kidney disease. J Urol 188:1239–1244

    Article  PubMed  Google Scholar 

  • Helal I et al (2011) Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6:2439–2443

    Article  PubMed Central  PubMed  Google Scholar 

  • Helal I et al (2012) Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease. Am J Nephrol 36:362–370

    Article  CAS  PubMed  Google Scholar 

  • Hildebrandt F, Benzing T, Katsanis N (2011) Ciliopathies. N Engl J Med 364:1533–1543

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hogan MC et al (2012) Somatostatin analog therapy for severe polycystic liver disease: results after 2 years. Nephrol Dial Transplant 27:3532–3539

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ibraghimov-Beskrovnaya O, Natoli TA (2011) mTOR signaling in polycystic kidney disease. Trends Mol Med 17:625–633

    Article  CAS  PubMed  Google Scholar 

  • Mangoo-Karim R, Uchic M, Lechene C, Grantham JJ (1989) Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP. Proc Natl Acad Sci USA 86:6007–6011

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Millar MB et al (2013) Surgical Cyst Decortication in Autosomal Dominant Polycystic Kidney Disease. J Endourol 27:528–534

    Article  PubMed Central  PubMed  Google Scholar 

  • Neumann HP et al (2012) Characteristics of intracranial aneurysms in the else kroner-fresenius registry of autosomal dominant polycystic kidney disease. Cerebrovasc Dis Extra 2:71–79

    Article  PubMed Central  PubMed  Google Scholar 

  • Pei Y et al (2009) Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 20:205–212

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pirson Y, Chauveau D, Torres V (2002) Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 13:269–276

    PubMed  Google Scholar 

  • Shillingford JM et al (2006) The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci USA 103:5466–5471

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Torres VE et al (2012a) Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int 81:577–585

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Torres VE, Harris PC, Pirson Y (2007) Autosomal dominant polycystic kidney disease. Lancet 369:1287–1301

    Article  PubMed  Google Scholar 

  • Torres VE et al (2012b) Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease. N Engl J Med 367:2407–2418

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Watnick T, Germino GG (1999) Molecular basis of autosomal dominant polycystic kidney disease. Semin Nephrol 19:327–343

    CAS  PubMed  Google Scholar 

  • Yoder BK, Hou X, Guay-Woodford LM (2002) The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J Am Soc Nephrol 13:2508–2516

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinikum Freiburg, Innere Medizin IV (Nephrologie und Allgemeinmedizin), Hugstetter Str. 49, 79106, Freiburg, Deutschland

    Prof. Dr. Gerd Walz

Authors
  1. Prof. Dr. Gerd Walz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerd Walz .

Editor information

Editors and Affiliations

  1. Medizinische Klinik I, Universitätsklinikum Schleswig-Hoslstein, Campus Lübeck, Lübeck, Schleswig-Holstein, Germany

    Hendrik Lehnert

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Walz, G. (2014). Autosomal dominante polyzystische Nierenerkrankung (ADPKD). In: Lehnert, H. (eds) SpringerReference Innere Medizin. SpringerReference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54676-1_63-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54676-1_63-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-54676-1

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Autosomal dominante polyzystische Nierenerkrankung (ADPKD)
    Published:
    27 December 2023

    DOI: https://doi.org/10.1007/978-3-642-54676-1_63-2

  2. Original

    Autosomal dominante polyzystische Nierenerkrankung (ADPKD)
    Published:
    25 November 2014

    DOI: https://doi.org/10.1007/978-3-642-54676-1_63-1

Search

Navigation